Cargando…
Emergence of SGLT2 Inhibitors as Powerful Antioxidants in Human Diseases
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of oral glucose-lowering agents. Apart from their glucose-lowering effects, large clinical trials assessing certain SGLT2 inhibitors have revealed cardiac and renal protective effects in non-diabetic patients. These excellent outcomes...
Autores principales: | Tsai, Kai-Fan, Chen, Yung-Lung, Chiou, Terry Ting-Yu, Chu, Tian-Huei, Li, Lung-Chih, Ng, Hwee-Yeong, Lee, Wen-Chin, Lee, Chien-Te |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388972/ https://www.ncbi.nlm.nih.gov/pubmed/34439414 http://dx.doi.org/10.3390/antiox10081166 |
Ejemplares similares
-
Urinary Exosomal MicroRNA Signatures in Nephrotic, Biopsy-Proven Diabetic Nephropathy
por: Lee, Wen-Chin, et al.
Publicado: (2020) -
Recent Advances in Microfluidic Devices for Contamination Detection and Quality Inspection of Milk
por: Ng, Hwee-Yeong, et al.
Publicado: (2021) -
The Number of Comorbidities Predicts Renal Outcomes in Patients with Stage 3–5 Chronic Kidney Disease
por: Lee, Wen-Chin, et al.
Publicado: (2018) -
Gelsolin and Progression of Aortic Arch Calcification in Chronic Hemodialysis Patients
por: Chiou, Terry Ting-Yu, et al.
Publicado: (2016) -
Oxidative Stress and Nonalcoholic Fatty Liver Disease in Hemodialysis Patients
por: Wu, Po-Jung, et al.
Publicado: (2018)